Hirokazu Iida
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Hirokazu Iida has a total of 24 co-authors. Here are the top co-authors by number of shared publications:
- Kenichi Oe
Department of Orthopaedic Surgery, Kansai Medical University, Hirakata, Osaka, Japan
3 shared publications - Susumu Ikehara
Kansai Medical University
2 shared publications - Taketoshi Kushida
Department of Orthopedic Surgery, Kansai Medical University, 10‐15 Fumizono‐cho, Moriguchi‐City, Osaka 570‐8506, Japan
2 shared publications B. Kolbasov
I.V. Kurchatov Institute of Atomic Energy, Ploshad Kurchatova 46, Moscow 123182, USSR
1 shared publication- Eiji Kondo
Centre for Sports Medicine Hokkaido University Hospital Sapporo Japan
1 shared publication - Fumito Kobayashi
Department of Orthopaedic Surgery, Kansai Medical University, Hirakata, Osaka, Japan
1 shared publication
Latest Publications
- 28 November 2024
- Published by Springer Nature
- p. 47-48
SC Stem (Kyocera)
- Open Access
- 6 December 2023
- Published by British Editorial Society of Bone & Joint Surgery in Bone & Joint Open
- Vol. 4 (12) , 932-941
The modified Spitzy shelf acetabuloplasty for the dysplastic hip
The modified Spitzy shelf acetabuloplasty for the dysplastic hip
- 6 December 2023
- Published by British Editorial Society of Bone & Joint Surgery in Bone & Joint Open
- Vol. 4 (12) , 932-941
Open AccessThe modified Spitzy shelf acetabuloplasty for the dysplastic hip
The modified Spitzy shelf acetabuloplasty for the dysplastic hip
- Open Access
- 30 May 2013
- Published by Springer Nature in BMC Musculoskeletal Disorders
- Vol. 14 (1) , 174
Development of a salmon-derived crosslinked atelocollagen sponge disc containing osteogenic protein-1 for articular cartilage regeneration: in vivo evaluations with rabbits
Background: We have developed crosslinked salmon-derived atelocollagen sponge, which has a denaturation temperature of 47 degrees Celsius. The purpose of this study is to evaluate the fundamental in vivo efficacy of the osteogenic protein (OP) -1 containing salmon-derived collagen sponge disc (SCS) on cartilage regeneration, using a rabbit model. Methods: A total of 24 rabbits were used in this study. In each animal, a full-thickness osteochondral defect was created in each femoral trochlea. Then, each 12 rabbits were randomly divided into the two groups. In Group I, an OP1-SCS disc was implanted into the defect in the right knee. In Group II, a SCS disc without OP-1 was implanted into the defect in the right knee. A control group of 12 rabbits was assembled from randomly-selected left knees from among the first two groups. In Group-III, we applied no treatment for a defect in the left knee to obtain the untreated control. All rabbits were sacrificed at 12 weeks after surgery. In each group, 10 animals were used for histological and immunohistological evaluations, and the remaining 2 were used for real-time polymerase chain reaction (PCR) analyses. Results: In Group I, a regenerated cartilage tissue rich in proteoglycan and type-2 collagen was found at 12 weeks, although the width was thicker than that of Group II. In Group II, the defect was filled with thick inhomogeneous tissues, including cartilage, fibrous, and bone tissues at 12 weeks. Concerning the gross observation and histological scores at 12 weeks, the ANOVA showed significant differences (p < 0.0001, and p < 0.0001, respectively). The post-hoc test indicated that the gross observation and histological scores of Group I was significantly greater than those of Groups II (p = 0.035, and p = 0.0104, respectively) and III (p < 0.0001, and p < 0.0001, respectively), while Group II was significantly greater than Group III (p = 0.0069, and p = 0.005, respectively). The real time PCR analysis showed that gene expression of type-2 collagen and aggrecan of Group I was greater than that of Group II. Conclusions: The present study clearly demonstrated that the implantation of the OP1-SCS disc without any cultured cells may induce spontaneous hyaline-like cartilage regeneration to greater degrees than implantation of only the salmon-derived collagen sponge disc.
- 30 May 2013
- Published by Springer Nature in BMC Musculoskeletal Disorders
- Vol. 14 (1) , 174
Open AccessDevelopment of a salmon-derived crosslinked atelocollagen sponge disc containing osteogenic protein-1 for articular cartilage regeneration: in vivo evaluations with rabbits
Background: We have developed crosslinked salmon-derived atelocollagen sponge, which has a denaturation temperature of 47 degrees Celsius. The purpose of this study is to evaluate the fundamental in vivo efficacy of the osteogenic protein (OP) -1 containing salmon-derived collagen sponge disc (SCS) on cartilage regeneration, using a rabbit model. Methods: A total of 24 rabbits were used in this study. In each animal, a full-thickness osteochondral defect was created in each femoral trochlea. Then, each 12 rabbits were randomly divided into the two groups. In Group I, an OP1-SCS disc was implanted into the defect in the right knee. In Group II, a SCS disc without OP-1 was implanted into the defect in the right knee. A control group of 12 rabbits was assembled from randomly-selected left knees from among the first two groups. In Group-III, we applied no treatment for a defect in the left knee to obtain the untreated control. All rabbits were sacrificed at 12 weeks after surgery. In each group, 10 animals were used for histological and immunohistological evaluations, and the remaining 2 were used for real-time polymerase chain reaction (PCR) analyses. Results: In Group I, a regenerated cartilage tissue rich in proteoglycan and type-2 collagen was found at 12 weeks, although the width was thicker than that of Group II. In Group II, the defect was filled with thick inhomogeneous tissues, including cartilage, fibrous, and bone tissues at 12 weeks. Concerning the gross observation and histological scores at 12 weeks, the ANOVA showed significant differences (p < 0.0001, and p < 0.0001, respectively). The post-hoc test indicated that the gross observation and histological scores of Group I was significantly greater than those of Groups II (p = 0.035, and p = 0.0104, respectively) and III (p < 0.0001, and p < 0.0001, respectively), while Group II was significantly greater than Group III (p = 0.0069, and p = 0.005, respectively). The real time PCR analysis showed that gene expression of type-2 collagen and aggrecan of Group I was greater than that of Group II. Conclusions: The present study clearly demonstrated that the implantation of the OP1-SCS disc without any cultured cells may induce spontaneous hyaline-like cartilage regeneration to greater degrees than implantation of only the salmon-derived collagen sponge disc.
- 1 December 2010
- Published by Wolters Kluwer Health in Journal of Bone and Joint Surgery
- Vol. 92 (17) , 2776-2784
Treating Achilles Tendon Rupture in Rats with Bone-Marrow-Cell Transplantation Therapy
Les tendon ruptures in a rat model with transplantation of whole bone marrow cells. Methods: Nine F344/Nslc (Fisher) rats were the source of bone marrow cells and mesenchymal stem cells as well as normal Achilles tendons. Eighty-seven Fisher rats were used for the experiments. The rats were divided into three groups: the BMC group (bone marrow cells injected around the tendon), the MSC group (mesenchymal stem cells injected around the tendon), and the non-treated control group (incision only). Outcome measures included mechanical testing, collagen immunohistochemistry, histological analysis, and reverse transcription-polymerase chain reaction to detect expression of transforming growth factor-β (TGF-β) and vascular endothelial growth factor (VEGF). Results: The ultimate failure load in the BMC group was significantly greater than that in the non-treated or the MSC group at seven days after incision (3.8 N vs. 0.9 N or 2.1 N, p < 0.016) and at fourteen days after incision (10.2 N vs. 6.1 N or 8.2 N, p < 0.016). The ultimate failure load in the BMC group at twenty-eight days after incision (33.8 N) was the same as that of normal tendon (34.8 N). The BMC group demonstrated stronger staining for type-III collagen at seven days after incision and stronger staining for type-I collagen at twenty-eight days than did the MSC group. Expression of TGF-β and VEGF in the BMC group was significantly increased compared with that in the other groups at four days after incision (TGF-β: 1.6 vs. 1.3 or 0.6, p < 0.01; VEGF: 1.7 vs. 1.1 or 0.9, p < 0.01). Conclusions: Transplantation of whole bone marrow cells may be a better and more readily available treatment for Achilles tendon rupture than cultured mesenchymal stem cells. Clinical Relevance: The present study provides evidence that transplantation of bone marrow cells may be a promising therapy for the treatment of Achilles tendon rupture....
- 1 December 2010
- Published by Wolters Kluwer Health in Journal of Bone and Joint Surgery
- Vol. 92 (17) , 2776-2784
Treating Achilles Tendon Rupture in Rats with Bone-Marrow-Cell Transplantation Therapy
Les tendon ruptures in a rat model with transplantation of whole bone marrow cells. Methods: Nine F344/Nslc (Fisher) rats were the source of bone marrow cells and mesenchymal stem cells as well as normal Achilles tendons. Eighty-seven Fisher rats were used for the experiments. The rats were divided into three groups: the BMC group (bone marrow cells injected around the tendon), the MSC group (mesenchymal stem cells injected around the tendon), and the non-treated control group (incision only). Outcome measures included mechanical testing, collagen immunohistochemistry, histological analysis, and reverse transcription-polymerase chain reaction to detect expression of transforming growth factor-β (TGF-β) and vascular endothelial growth factor (VEGF). Results: The ultimate failure load in the BMC group was significantly greater than that in the non-treated or the MSC group at seven days after incision (3.8 N vs. 0.9 N or 2.1 N, p < 0.016) and at fourteen days after incision (10.2 N vs. 6.1 N or 8.2 N, p < 0.016). The ultimate failure load in the BMC group at twenty-eight days after incision (33.8 N) was the same as that of normal tendon (34.8 N). The BMC group demonstrated stronger staining for type-III collagen at seven days after incision and stronger staining for type-I collagen at twenty-eight days than did the MSC group. Expression of TGF-β and VEGF in the BMC group was significantly increased compared with that in the other groups at four days after incision (TGF-β: 1.6 vs. 1.3 or 0.6, p < 0.01; VEGF: 1.7 vs. 1.1 or 0.9, p < 0.01). Conclusions: Transplantation of whole bone marrow cells may be a better and more readily available treatment for Achilles tendon rupture than cultured mesenchymal stem cells. Clinical Relevance: The present study provides evidence that transplantation of bone marrow cells may be a promising therapy for the treatment of Achilles tendon rupture....
- 1 January 2002
- Published by The Medical Society of Kansai Medical University in The Journal of Kansai Medical University
- Vol. 54 (2-4) , 136-149
powerful new strategy for allogeneic bone marrow transplantation in mice
- 1 January 2002
- Published by The Medical Society of Kansai Medical University in The Journal of Kansai Medical University
- Vol. 54 (2-4) , 136-149
powerful new strategy for allogeneic bone marrow transplantation in mice
- 1 December 1991
- Published by Elsevier in Fusion Engineering and Design
- Vol. 16, 35-43
Safety analysis and radioactivity confinement for ITER
- 1 December 1991
- Published by Elsevier in Fusion Engineering and Design
- Vol. 16, 35-43
Safety analysis and radioactivity confinement for ITER